Mera Vada, in collaboration with Novo Nordisk
recently hosted a CME on Rybelsus, the leading US FDA-approved patented drug for diabetes and weight management. Eminent physicians shared valuable insights during the session. Staying true to its vision, Mera Vada continues to support innovation and empower the next generation of healthcare professionals in exploring advancements in medical science.
